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Angiotensin-(1–7)  has been  described  as  a new potential  therapeutic  tool  for the treatment  and  pre-
vention  of  metabolic  disorders  by  regulating  several  pathways  in  visceral  white  adipose  tissue  (vWAT).
The aim  of this  study  was to access  the  proteins  differentially  regulated  by Ang-(1–7)  using  proteomic
analysis  of visceral  adipose  tissue.  Male  mice  were  divided  into  three  groups  and  fed for 60 days,  with
each  group  receiving  one  of the  following  diets:  standard  diet  + HPCD  (ST),  high  fat  diet + HPCD  (HFD)
and  high  fat  diet  +  Ang-(1–7)/HPCD (HFD  + Ang-(1–7)).  Body  weight,  fat weight  and  food intake  were
measured.  At  the end  of treatment,  Ang-(1–7)  induced  a decrease  in  body  and  fat weight.  Differential  pro-
teomic  analysis  using  two-dimensional  electrophoresis  (2-DE)  combined  with  mass  spectrometry  were
performed.  Results  of  protein  mapping  of  mesenteric  adipose  tissue  using  2-DE  revealed  the  presence
of  about  450  spots  in each  gel  (n = 3/treatment)  with  great  reproducibility  (>70%).  Image  analysis  and
further  statistical  analysis  allowed  the  detection  and identiﬁcation  of  eight  proteins  whose  expression
was  modulated  in  response  to  HFD  when  compared  to  ST.  Among  these,  two proteins  showed  a  sensi-
tive  response  to  Ang-(1–7)  treatment  (eno1  and aldehyde  dehydrogenase).  In  addition,  three  proteins
were  expressed  statistically  different  between  HFD  + Ang-(1–7)  and  HFD  groups,  and four  proteins  were
modulated  compared  to  standard  diet.  In  conclusion,  comparative  proteomic  analysis  of a mice  model
of diet-induced  obesity  allowed  us to outline  possible  pathways  involved  in the  response  to  Ang-(1–7),
suggesting  that  Ang-(1–7)  may  be a useful  tool  for the  treatment  of metabolic  disorders.∗ Corresponding author at: Pharmacology Department, Federal University of
inas Gerais (UFMG), Av. Antonio Carlos 6627 – ICB, Belo Horizonte 31270-901,
inas Gerais, Brazil. Tel.: +55 31 3409 2712; fax: +55 31 3409 2712.
E-mail address: sergiosousas@hotmail.com (S.H.S. Santos).
1 These two authors are contributed equally to this study.
ttp://dx.doi.org/10.1016/j.peptides.2014.07.023
196-9781/© 2014 Elsevier Inc. All rights reserved.© 2014  Elsevier  Inc.  All  rights  reserved.
Introduction
Obesity is a serious and growing world health problem. Current
epidemiological estimates suggest that 1.1 billion people world-
wide are above their ideal weight [20], which is characterized by
an increase in white adipose tissue mass as result of an excess of
food (energy) intake or altered energy expenditure [14]. Obesity
has been recently described as both a systemic and local adipose
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roinﬂammatory state, and is recognized as a cause of health
ssues, such as insulin resistance, diabetes, hyperlipidemia, hyper-
ension, and cardiovascular disease [23,31,42]. Classic markers of
he obesity-induced inﬂammatory state include augmented circu-
ating and tissue levels of proinﬂammatory enzymes, procoagulant
actors, cytokines, and chemokines [15,42].
Visceral white adipose tissue (vWAT) has been identiﬁed as
n important organ that directly and indirectly modulates inﬂam-
ation and metabolism through pathways in various organs,
uch as the brain, liver, muscle and vascular endothelial cells
30]. Therefore, inhibition of excess vWAT could be an efﬁcient
trategy for the prevention of obesity and metabolic disor-
ers.
The renin–angiotensin system (RAS) is now recognized as an
mportant in the development of cardiovascular and metabolic
isorders [25,28,29]. Angiotensin II (Ang II), a major effector of
AS, is known as a vasoconstrictor, however, a recent study has
hown its role as a potential mediator in the activation of inﬂam-
atory mechanisms involved in obesity [5,36]. On the other hand,
he angiotensin converting enzyme 2 (ACE2)/angiotensin-(1–7)
ng-(1–7)/Mas axis has been suggested as an important counter-
egulatory arm in the RAS with the opposite effects of ACE/Ang
I/AT1 [25,27]. Ang-(1–7) exerts an important antiobesity role
hrough the Mas  receptor [27–29].
Recently, Rubio-Ruíz et al. found that the expression patterns
f AT1 and AT2 receptors were signiﬁcantly diminished and Mas
xpression increased with aging in the adipose tissue of rats with
etabolic syndrome [24]. Additionally, Santos et al. [23] showed
hat Mas  is expressed in adipose tissue and that Mas-deﬁcient mice
evelop a metabolic syndrome-like state. In another study, Marcus
t al. showed that chronic treatment with Ang-(1–7) for six months
pregulated Mas  expression in the epididymal fat of rats fed a high
ructose diet [19].
Actually, the pharmacological effects of Ang-(1–7) were
ncreased after the development of a new oral formulation
haracterized by a protected Ang-(1–7) molecule included in
cyclic-oligosaccharides (cyclodextrin). This novel compound
as denominated [hydroxypropyl-cyclodextrin/Ang-(1–7) –
PCD/Ang-[1–7)] [18]. Ang-(1–7), enclosed within this HPCD,
an be protected during the passage through the gastrointestinal
ract after oral administration [11].
Recent studies indicated the important role of ACE2/Ang-
1–7)/Mas axis in metabolic functions in various organs and
issues. Santos et al. showed that Mas  receptor deﬁciency in
VB/N mice induced dyslipidemia, lowered glucose tolerance and
nsulin sensitivity, decreased glucose uptake in white adipose
ells, and an increase in adipose tissue mass [28]. Subsequent
tudies demonstrated improved lipid and glucose metabolism
ssociated with decreased liver gluconeogenesis in transgenic
ats with high-circulating Ang-(1–7) plasma levels [27]. In the
ast year, two new reports indicated an important role of
he ACE2/Ang-(1–7)/Mas axis in the liver, suggesting that oral
reatment with Ang-(1–7) induces improvement the status of
teatohepatitis, as well as reduces adipogenesis-related markers
3,10,21,26].
Proteome analysis has recently been used in many studies of
besity, diabetes, aging and cancer [12,17,22,40]. The combina-
ion of MALDI-TOF/TOF Tandem Mass Spectrometry is a powerful
ethod for the discovery of new biomarkers and pathways in a
umber of diseases. Nowadays, the proﬁling and discovery of novel
iomarkers for diagnosis of disease-related obesity, as well as for
ccurate understanding of mechanisms and causes of metabolic
isorders, are needed.
Thus, the aim of this study is to access the proteins differentially
egulated by Ang-(1–7) using two-dimensional gel electrophore-
is (2DE) associated with the approach of MALDI-TOF/TOF Tandemdes 60 (2014) 56–62 57
Mass Spectrometry in visceral white adipose tissue samples of the
mice.
Methods and materials
Drug
Angiotensin-(1–7) associated with hydroxypropyl-
cyclodextrin [HPCD]/Ang-(1–7). Was  donated by Robson Santos
(National Institute of Science and Technology – INCT-NanoBiofar).
Daily dose (concentration of 100 g/kg) [26].
Animals
The experiment was conducted with twenty-four male FVB/N
mice (four weeks old) from the State University of Montes Claros
(Montes Claros, Minas Gerais, Brazil). The mice were individually
housed and placed in an air-conditioned room (22 ± 2 ◦C) with a
12 h light-dark cycle. After 7 days of the adaptation period, the
mice were randomly divided into three groups (n = 8) and fed the
following experimental diets for 8 weeks: G1: standard diet (ST);
G2: high fat diet (HFD); G3: high fat diet plus angiotensin-(1–7)
(HFD + Ang-(1–7)). The mice had free access to food and water dur-
ing the experimental period.
All experimental procedures were approved by the Ethics Com-
mittee of the State University of Montes Claros for the care and use
of the laboratory, and were conducted in accordance with the reg-
ulations described in the Committee’s Guiding Principles Manual.
Diets
High-fat diet was  prepared according to the protocols described
previously [26], being composed of 24.0% carbohydrate, 15.0% pro-
tein and 61.0% fat, presenting a total of 5.28 kcal per 1 g of diet.
Standard diet (Purina – Labina®), which was used for the regular
maintenance of our mice, was composed of 66.0% carbohydrate,
23.0% protein and 11.0% fat presenting a total of 3.95 kcal per 1 g of
diet [1,6]. All of the high-fat diet components were purchased from
Rhoster® LTDA (São Paulo, São Paulo, Brazil).
Measurements of body weight, food intake and tissue collection
The mice were individually housed and the food intake was
measured daily during treatment in order to obtain food efﬁciency
(food intake/body weight). Overnight fasted (12 h) mice were killed
with Ketalar® (Pﬁzer Laboratório, São Paulo, Brazil) (Ketamine,
130 mg/kg) and Dorcipec® (Vallé S/A, Montes Claros, MG,  Brazil)
(0.3 mg/kg) after anesthesia. Samples of the mesenteric white adi-
pose tissue were collected, weighed and immediately frozen in dry
ice and stored at −80 ◦C for subsequent analysis.
Bidimensional electrophoresis
Two-dimensional gel electrophoresis (2-DE) using the IPG-
DALT subsequent MALDI-TOF-TOF MS  analyses were performed.
Brieﬂy, to extract total protein, frozen mesenteric mouse adipose
tissue (n = 8) from ST, HFD, and HFD + Ang-(1–7) were homog-
enized overnight in extract buffer containing 8 M urea, 2 M
thiourea, 4% (w/v) 3-[(3-cholamidopropyl)dimethylammonio]-
1-propanesulfonate (CHAPS), 65 mM dithiothreitol (DTT), 1 M
Tris–HCl and 1% protease inhibitor cocktail (GE Healthcare®). Sam-
ples were centrifuged at 20,000 × g for 30 min, and the supernatants
were collected. The protein content was  determined using a 2-D
Quant Kit (GE Healthcare®).
After removal of impurities with Cleanup kit (GE Healthcare),
strips (Immobiline Dry Strip pH 3-10NL, 13 cm – GE Healthcare)
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ere passively rehydrated with approximately 300 g of extracted
roteins diluted in rehydration solution (8 M urea, 2 M thiourea,
% (w/v) CHAPS, 65 mM DTT, 1 M Tris–HCl and trace bromophe-
ol blue). First-dimensional isoelectric focusing was  performed at
0 ◦C starting at 500 V with the voltage being gradually increased to
000 V, totaling 45,000 Vh accumulations, using EttanTM IPGphorTM
 IEF power supply (GE Healthcare®) and IPGphor software (GE
ealthcare®). After the electrofocusing procedure, the gel strips
ere equilibrated twice for 15 min  shaking in 3 mL  of equilibra-
ion buffer (6 M urea, 50 mM Tris–HCl pH 8.8, 30% (v/v) glycerol, 2%
w/v) SDS and 0.001% w/v  bromophenol blue) containing 65 mM
TT or 135 mM IAA. In the second dimension SDS-PAGE, the equi-
ibrated gel strips were placed on the top of 12% polyacrylamide
els, sealed with 0.1% (w/v) agarose and run at 50 mA/gel in SDS
unning buffer (25 mM Tris–HCl, 192 mM glycine and 0.1% (w/v)
DS) until the front dye reached the bottom of the gel (Ettan
ALT six electrophoresis unit, GE Healthcare®). The gel was ﬁxed
ith a sequence of steps (1–2% (v/v) orthophosphoric acid, 30%
v/v) ethanol; 2–2% (v/v) orthophosphoric acid and 3–2% (v/v)
rthophosphoric acid, 18% (v/v) ethanol and 12% (w/v) ammonium
ulfate). Finally, the gel was stained with Coomassie G-250 (0.08%
w/v)) for 5 days, when the background was destained with 20%
thanol (v/v) for image acquisition and analysis.
mage acquisition and analysis
The gels were scanned using an Amersham Image Scanner II
GE Healthcare®) and analyzed using ImageMaster 2D Platinum
oftware (GE Healthcare®). These programs group images of the
els into classes containing biological triplicates of each condition.
nitially, we evaluated the reproducibility of two-dimensional gels
or each condition. The authenticity of each spot was evaluated by
isual inspection and conﬁrmed using the software, with the spots
eing excluded or added when necessary. The percentage volume
f each spot was recorded and normalized according to the total
ntensity of the spots detected.
ryptic digestion in polyacrylamide gel
The differentially expressed spots were excised from the gels
nd detained in a solution of 50% (v/v) acetonitrile/25 mM ammo-
ium bicarbonate pH 8.0, with three washes of 15 min  each, while
haking in a vortex mixer. The gels were then dehydrated in ace-
onitrile for 5 min  and dried in a SpeedVac (Savant). The dehydrated
ragments on the gels were digested at 37 ◦C overnight with trypsin
Promega cat. #V511) at 20 ng/mL in 25 mM ammonium bicarbon-
te. The resulting peptides were then extracted with 5% (v/v) formic
cid for 30 min  with constant stirring (vortex). Finally, the pep-
ides were concentrated in a SpeedVac (Savant), to a ﬁnal volume
f 10 L. The samples were passed through a Zip-Tip (C18 resin, p
, Millipore Corporation, Bedford, MA)  to remove salts. The column
lution of peptides was performed in 50% (v/v) acetonitrile/triﬂuoro
cetic acid (TFA) 0.1%. The samples were stored at −70 ◦C prior to
urther analysis by mass spectrometry.
able 1
ffects of Ang-(1–7) on body and mesenteric WAT  weight in mice fed with a high-fat diet
Group Final weight (g) Initial weight (g) Final weight (g) - In
ST 32.12 21.77 10.35 ± 2.01**
HFD 37.89 23.04 14.85 ± 1.87 
HFD  + Ang-(1–7) 34.67 23.15 11.52 ± 1.58*
tandard diet group (ST). High-fat diet group (HFD). High-fat diet plus Ang-1–7 [HFD + An
* P < 0.05 in comparison to the HFD group.
** P < 0.01 in comparison to the HFD group.
ata are mean ± SEM (n = 8 per group).des 60 (2014) 56–62
Mass spectrometry
Time-of-ﬂight mass spectrometry (TOF-MS) matrix-assisted
laser desorption/ionization (MALDI) was  conducted in a MALDI-
TOF-TOF Autoﬂex III SmartBeam system (Bruker Daltonics®).
Samples of peptides were mixed with twice the volume of
a saturated solution of the matrix -cyano-4-hydroxycinnamic
acid (Sigma–Aldrich®) in 50% (v/v) acetonitrile/TFA 0.1% in a
MALDI plate. MS  mass spectra and MS/MS  were acquired in
reﬂector mode and internally calibrated with peptides cleaved
by trypsin. Up to eight of the most intense ion signals were
selected as precursors for the acquisition of MS/MS. The inter-
nal calibration mode MS  was performed using a mixture of
four peptides: des-Arg 1-Bradykinin (m/z = 904.468), angiotensin I
(m/z = 1296.685), Glu1-ﬁbrinopeptide B (m/z = 1570.677) and ACTH
(18–39) (m/z = 2465.199). The spectrum MS/MS  was externally cali-
brated using the fragmentation/mass known spectrum observed in
MS/MS  angiotensin I. The tandem mass spectrum was submitted
to the non-redundant Swiss-Prot database using MASCOT software
(http://www.matrixscience.com). The search parameters were as
follows: no restrictions on molecular weight, all entries of origin,
two wrong trypsin cleavages, variable modiﬁcations of methionine
(oxidation), cysteine (carbamidomethylation), pyroglutamate and
the formation of the N-terminal glutamine of peptides.
Statistical analysis
Data were expressed as the mean ± SEM. The statistical signif-
icance of differences in mean values between mice groups were
assessed by one-way and the Bonferroni post test. Signiﬁcance level
was set at P < 0.05. Student’s t-test was used to compare the per-
centage spot volume for each condition, and those that showed
signiﬁcant differences between the two  classes were selected for
identiﬁcation by mass spectrometry.
Results
Effect of Ang-(1–7) on body and VAT weights
Ang-(1–7) treatment decreased body weight in HFD + Ang-(1–7)
mice when compared with HFD during the period of treatment
(Table 1). We  did not observe signiﬁcant alterations between
groups when the food efﬁciency was evaluated (food intake/body
weight) (Table 1). Analysis of mesenteric visceral adipose tissue
(ST: 0.0129 ± 0.0039 g/g BW;  HFD: 0.0198 ± 0.0031; HFD + Ang-
(1–7): 0.0151 ± 0.0034) demonstrated a reduced fat composition
in HFD + Ang-(1–7) (Table 1).
Proteomic analysis of vWAT
Results of protein mapping of mesenteric adipose tissue using
2-DE revealed that about 450 spots were observed in each gel
(n = 3/treatment) with a great reproducibility (>70%) (Figs. 1 and 2).
Image analysis and further statistical analysis allowed detection
and identiﬁcation of eight spots whose expression was modulated
.
itial weight (g) Food intake (g/day/BW) Mesenteric fat weight (g/BW)
0.172 ± 0.012 0.0052 ± 0.0031**
0.181 ± 0.015 0.0073 ± 0.0054
0.179 ± 0.014 0.0058 ± 0.0028*
g-(1–7)].
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tig. 1. Representative 2-DE gel images of Coomassie-stained proteins of VAT. Arrow
roup  (HFD). (C) High-fat diet plus Ang-1–7 [HFD + Ang-(1–7)]. IEF was performed 
olyacrylamide gel.
n response to HFD when compared to ST. Among those, two pro-
eins showed a sensitive response to Ang-(1–7) treatment. Beside
his, three proteins were expressed statistically different between
ng-(1–7), HFD and four proteins modulated by standard diet
Fig. 1).
In particular, protein levels of protein disulﬁde-isomerase A3
recursor, alpha-actin, carbonic anhydrase 2 and unnamed pro-
ein product were up-regulated after HFD feeding (Table 2), when
ompared to ST, while eno1 protein, aldehyde dehydrogenase,
itochondrial precursor, ATP synthase, H+ transporting, mitochon-
rial F1 complex, alpha subunit, isoform 1, isoform CRA e and
ytosolic malate dehydrogenase were down-regulated.
ig. 2. The reproducibility of the gels of each experimental condition. Scatter plots show
tandard diet group (ST). (B) High-fat diet group (HFD). (C) High-fat diet plus Ang-1–7 [HF
he  gels.cate differentially regulated proteins. (A) Standard diet group (ST). (B) High-fat diet
trips of 13 cm,  pH 3–10 non-linear. The second dimension was performed on 12%
To identify the effects of Ang-(1–7) in HFD-induced obese
mice, we characterized the statistical difference between HFD and
HFD + Ang-(1–7). Consequently, there were ﬁve differential pro-
teins between these groups. Among them, expression levels of
carbonic anhydrase 2, eno1 protein and aldehyde dehydrogenase
mitochondrial precursor proteins, in HFD + Ang-(1–7) group were
signiﬁcantly increased and monoglyceride lipase, annexin A2 and
cytosolic malate dehydrogenase were decreased compared with
the HFD group (P < 0.05). The incremental difference of Eno1 pro-
tein and aldehyde dehydrogenase proteins was the most signiﬁcant
compared with other proteins (Table 2) because these same pro-
teins were increased in the ST group in relation to the HFD group.
 the high correlation between the volume percentage of the spots in the gels. (A)
D + Ang-(1–7)]. Correlation index (Corr.) = 1 indicates complete correlation between
60 J.M.O. Andrade et al. / Peptides 60 (2014) 56–62
Table 2
List of Identiﬁed proteins in visceral white adipose tissue of mice fed with standard diet (ST), high fat diet (HFD) and HFD + Ang-(1–7).
Spot ID Protein GI pI Mass Da Coverage % Mascot score Abundance (P < 0.05)
3 Carbonicanhydrase 2 gi|33243954 6.52 29,138 11 102 HFD  > HFD + Ang-(1–7)
ST > HFD + Ang-(1–7)
6  Peroxiredoxin-1 gi|6754976 8.26 22,390 16 214 ST > HFD + Ang-(1–7)
8 Monoglyceride lipase isoform b gi|6754690 6.67 33,708 21 261 HFD  > HFD + Ang-(1–7)
ST > HFD + Ang-(1–7)Monoglyceride lipase isoform a gi|261878516 7.21 35,633 20 260
10  Annexin A2 gi|6996913 7.55 38,937 9 204 HFD  > HFD + Ang-(1–7)
14  Eno1 protein gi|34784434 5.86 40,099 17 219 ST > HFD
HFD  + Ang-(1–7) > HFD
17  Proteindisulﬁde-isomerase A3
precursor
gi|112293264 5.88 57,099 6 89 HFD  > ST
18  Aldehydedehydrogenase,
mitochondrial precursor
gi|6753036 7.53 57,015 5 122 ST > HFD
HFD  + Ang-(1–7) > HFD
ST > HFD + Ang-(1–7)
19  Alpha-actin (aa 40–375) gi|49864 5.45 38,016 6 97 HFD  > ST
20  Unnamed protein product gi|74191399 5.29 41,994 14 209 HFD  > ST
HFD  + Ang-(1–7) > ST
35  ATP synthase, H+ transporting,
mitochondrial F1 complex,
alpha subunit, isoform 1,
isoform CRAe
gi|148677501 8.24 54,675 8 84 ST > HFD
45  cytosolicmalatedehydrogenase,
partial
gi|387129 6.16 36,625 10 209 ST > HFD
ST > HFD + Ang-(1–7)
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CI: NCBlnr database accession number. Coverage: percent of identiﬁed sequence to
veraged and expressed as a mean (SEM of three separate experiments).
Three proteins (peroxiredoxin-1, monoglyceride lipase and
ldehyde dehydrogenase, mitochondrial precursor) were down-
egulated in the HFD + Ang-(1–7) when compared to ST group
Table 2). Only unnamed protein product was up-regulated in
FD + Ang-(1–7) (Table 2). However, protein disulﬁde-isomerase
3 precursor and alpha-actin, which were increased in ST group
hen compared with HFD, did not show differences between ST
nd HFD + Ang-(1–7) group. In the same way, the expression of ATP
ynthase, H+ transporting, mitochondrial F1 complex, alpha sub-
nit, isoform 1, isoform CRA e and cytosolic malate dehydrogenase
ere modiﬁed when compared between ST and HFD + Ang-(1–7),
nlike when observed between HFD and ST groups.
iscussion
The present study analyzed the antiobesity effect of Ang-(1–7)
n HFD-fed mice through proteomic analysis of visceral WAT. The
ost striking results from our proteomic study showed global
hanges in causative proteins associated with obesity; three of
hese proteins were examined for the ﬁrst time for their regulatory
ctions in regard to obesity: carbonic anhydrase 2, monoglyceride
ipase and annexin A2.
In our study, we observed an increase in carbonic anhydrases
CAs) expression in HFD group in comparison with Ang-(1–7) mice.
As are ubiquitous metalloenzymes and include at least ﬁve dis-
inct CA families (a–e). The primary function of CA is to catalyze
he reversible hydration of carbon dioxide to form bicarbonate and
rotons. In mammals, 16 isozymes have been identiﬁed showing
 difference in catalytic activity, subcellular localization and tissue
istribution [33].
CAs regulate many functions in homeostasis, such as pH reg-
lation, ion transport, bone resorption and secretion of gastric,
erebrospinal ﬂuid and pancreatic juices [34]. The most impor-
ant function of CA is related to the respiration and transport of
O2/bicarbonate in various metabolizing tissues. This enzyme is
lso involved in electrolyte secretion, CO2 and pH homeostasis, CO2
xation and biosynthetic reactions such as gluconeogenesis and
reagenesis [32]. Additionally, many CAs, like CA 2, have been drug
argets for a long time for the treatment of obesity [7,8,35]. Thus,
A inhibitors may  provide a novel therapy for obesity.mplete sequence of the known protein. For each protein, the relative intensity was
Recently, the role of CAs was indicated in diabetes [9,39,41].
Studies have been shown CAs to play a major role in dia-
betic microangiopathy and diabetic cardiomyopathy [39]. Torella
et al. showed that CA 2 is activated by high glucose levels
and directly induces cardiomyocyte hypertrophy and death in
vitro. CA 2 was  shown to be a direct target for repression by
microRNA-23b, which was downregulated in myocardial samples
from diabetes mellitus type 2 patients. MicroRNA-23b is regulated
by p38 mitogen-activated protein kinase, and it modulates high-
glucose CA 2-dependent effects on cardiomyocyte survival in vitro
[39].
Other important protein involved in metabolic regulation is
monoglyceride lipase (MGL), which was  down-regulated in the
HFD + Ang-(1–7) group. Studies showed increases in monoglyc-
eride lipase (MGL) expression and activity in mice fed with a high
fat diet, thus suggesting a potential role for MGL  in dietary lipid
assimilation [4]. Another study showed that monoglyceride lipase
inﬂuences energy metabolism through at least two  mechanisms.
First, it hydrolyzes monoacylglycerols (MG) into fatty acids and
glycerol, which can be used for energy production or synthetic
reactions. Second, MGL  degrades 2-arachidonoyl glycerol (2-AG),
the most abundant endogenous ligand of cannabinoid receptors
(CBR). Activation of CBR affects energy homeostasis by central orex-
igenic stimuli by promoting lipid storage and reduction of energy
expenditure [38]. These results demonstrate that MGL  deﬁciency
in mice reduces lipolysis and VLDL synthesis and attenuates high
fat diet-induced insulin resistance [38].
The last protein analyzed, is a member of annexin family. Annex-
ins are calcium-dependent phospholipid binding proteins that are
more divergent in function than structure [13]. This protein family
is comprised of at least 20 members that share a highly conserved
and tightly packed -helical core domain, as well as calcium and
phospholipid binding domains [13].
Annexin A2 is unique among the annexins and it is known to
function largely in a heterotetramer form, composed of two 36-
kDa subunits of annexin A2 (p36) complexed with two  11-kDa
S100A10 protein subunits (p11). This protein is highly expressed
on the surface of macrophages, where it enjoys promiscuous bind-
ing with several proteins, thus participating in many facets of
macrophage biology. Additionally, it was  also demonstrated that
annexin 2 plays a crucial role in the phagocytosis of apoptotic
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ymphocytes, an event at the end of an immune response, which
esults in the reduction of inﬂammation by the release of immuno-
uppressive cytokines [37]. However, evidence is beginning to
ccumulate regarding to the role of soluble, extracellular annex-
ns in inﬂammation and the immune response, which may  not be
hat simple.
Recently, it was shown that annexin 2 acts by activating ERK
AP  kinases in stromal cells [16]. MAP  kinases are key regu-
ators of macrophage activation [2]. It is reasonable to assume
hat annexin 2 might stimulate this pathway, and thus, cells
hedding annexin 2 could capitalize on this additional func-
ion as an inﬂammatory mediator. Additionally, Swisher et al.
howed that annexin 2 activates macrophages, stimulating MAP
inase and NF-B signaling pathways and induces the pro-
uction of three key cytokines involved in the establishment
f inﬂammation: TNF-, IL-1, and IL-6. These important but
otentially damaging inﬂammatory mediators taper off quickly
37].
onclusion
In conclusion, comparative proteome analysis of the mice model
f diet-induced obesity allowed us to outline possible pathways
nvolved in the response to Ang-(1–7). Proteins identiﬁed here are
nvolved in cellular functions that include lipid metabolism, redox
rocesses, and signal and energy transduction. Some of these have
lready been linked to obesity and its associated disorders; suggest-
ng that the newly identiﬁed proteins might also have importance
n obesity, and thus require further investigation. These changes
rovide valuable new molecular insights into the mechanism of the
ntiobesity effects of Ang-(1–7). Thus, we believe that the ﬁndings
resented in this paper will lead to new insights into the under-
tanding of this pathology as well as potential treatments.
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